Abstract PD3-03: SOLTI-1303 PATRICIA phase II trial (STAGE 1) -- Palbociclib and trastuzumab in postmenopausal patients with HER2-positive metastatic breast cancer

2019 ◽  
Author(s):  
E Ciruelos ◽  
P Villagrasa ◽  
L Paré ◽  
M Oliveira ◽  
S Pernas ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Metastatic Breast ◽  
Her2 Positive ◽  
Stage 1

A Phase II Trial of Oxaliplatin and Trastuzumab in the Treatment of HER2-Positive Metastatic Breast Cancer

2010 ◽  
Vol 28 (8) ◽  
pp. 865-871 ◽  
Author(s):  
Denise A. Yardley ◽  
Davey Daniel ◽  
Michael Stipanov ◽  
D. Randolph Drosick ◽  
Mark Mainwaring ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Metastatic Breast ◽  
Her2 Positive

A phase II trial of trabectedin (T) in patients (pts) with HER2-positive and BRCA1/2 germ-line-mutated metastatic breast cancer (MBC).

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. 1038-1038 ◽  
Author(s):  
K. L. Tedesco ◽  
J. L. Blum ◽  
A. Goncalves ◽  
J. Lubinski ◽  
N. Ben-Baruch ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Germ Line ◽  
Phase Ii Trial ◽  
Metastatic Breast ◽  
Her2 Positive
Sign in / Sign up

Export Citation Format

Share Document